Exit readiness for specialty and surgical clinics requires per-procedure economics that survive diligence, scheduling utilization that justifies fixed costs, and a case mix and payer mix that produce durable contribution margin independent of the owner.
No cost. 15 minutes. No obligation.
Exit readiness for specialty and surgical clinics requires per-procedure economics that survive diligence, scheduling utilization that justifies fixed costs, and a case mix and payer mix that produce durable contribution margin independent of the owner.
Buyers pay 5 to 17x EBITDA for specialty and surgical clinics, but only when earnings reflect true contribution margin per procedure, not blended averages that hide low-margin cases. Many clinics run scheduling utilization below 70%, carry adverse payer mix weighted toward capitated or bundled contracts, and depend entirely on the owner for clinical decision-making and case selection. When institutional buyers model contribution margin by CPT code, payer, and surgeon, earnings frequently recast downward by 20% to 40%. Exit readiness means building a business where per-procedure economics, block time utilization, and clinical leadership hold up under private equity or strategic acquirer scrutiny, not assembling a deck in the final quarter.
Contribution margin analysis by CPT code, payer, and surgeon, isolating per-procedure economics and flagging cases that fail to cover direct clinical labor and consumables
Scheduling utilization model by block time, day-part, and provider, quantifying current capacity, under-utilized slots, and revenue opportunity from improved fill rates
Payer mix and case mix matrix showing revenue, margin, and concentration risk by contract and procedure category, with diligence-ready recast schedules
Clinical leadership transition roadmap that documents protocols, case selection criteria, and peer supervision structures independent of the owner
Quality of earnings workbook prepared to institutional diligence standards, with normalized EBITDA, owner compensation addbacks, and per-procedure margin bridges that survive buyer scrutiny
Three-year operating model that projects revenue per case, contribution margin per procedure, and scheduling utilization under buyer ownership assumptions, not seller optimism
Specialty and surgical clinics command 5 to 17x EBITDA depending on scale, specialty mix, and operational maturity. Single-specialty ASCs trade at 5 to 8x, multi-specialty platforms at 6 to 10x, and regional operators with management infrastructure at 11 to 17x. Buyers pay the higher end of the range when per-procedure economics are transparent, scheduling utilization exceeds 80%, payer mix is diversified across commercial contracts, and clinical leadership operates independently of the seller. Non-controlling interests settle at 3 to 6x because operational control and post-close margin improvement remain with the majority owner, not the buyer.
See the healthcare multiples benchmark for where specialty and surgical clinics transact today.
Buyers do not pay a multiple on the EBITDA you report. They pay it on the EBITDA they accept after add-backs.
Where healthcare practices transact today, by vertical, on normalized EBITDA.
| Vertical | EBITDA multiple | Basis | Source |
|---|---|---|---|
| Ambulatory Surgery Centers | 5 to 17x | EBITDA; single to multi-specialty to operator platforms | FOCUS Investment Banking |
exit readiness and m&a for specialty and surgical clinics is the intersection page. Read the full specialty and surgical clinics advisory angle, the general exit readiness and m&a overview, or run the Value Creation Assessment to see where your practice stands.
Buyers isolate contribution margin by CPT code and payer, then remove cases where reimbursement fails to cover direct clinical labor, consumables, and allocated block time cost. If 15% of case volume produces negative contribution margin, buyers recast EBITDA downward and reduce the multiple. We build per-procedure economics before marketing so normalized EBITDA reflects actual margin durability, not blended averages that collapse under scrutiny.
Private equity buyers model 75% to 85% block time utilization as a floor for defensible margin. Clinics running below 70% face recast risk because fixed staffing and facility costs are spread over fewer cases, compressing contribution margin per procedure. We build utilization models by surgeon, day-part, and procedure type so you can demonstrate capacity discipline and identify revenue expansion opportunities before a buyer models them as post-close cost cuts.
Concentration in one or two commercial contracts introduces reimbursement risk that buyers discount through lower multiples or earnout structures tied to contract renewal. Case mix weighted toward bundled or capitated payment models compresses future margin, limiting buyer universe to strategic acquirers with existing risk contracts. We quantify payer and case mix concentration, model contract loss scenarios, and diversify revenue sources before diligence so your EBITDA multiple reflects margin stability, not revenue volatility.
Eighteen to thirty-six months if contribution margin per procedure must be rebuilt, scheduling utilization is below 70%, or clinical leadership resides entirely with the owner. Six to twelve months if per-procedure economics are already transparent, block time is efficiently utilized, and a physician or clinical director can operate independently post-close. We phase readiness work across margin improvement, utilization gains, and leadership transition so the business can survive quality of earnings review and post-close operational integration without earnings degradation.
We build forward-looking cash visibility tailored to the case-mix economics of specialty and surgical clinics, so you…
See the specialty and surgical clinics angleSpecialty and surgical clinics face entity structure, owner compensation, and retirement vehicle decisions that shift…
See the specialty and surgical clinics angleSpecialty and surgical clinics generate revenue per case and per procedure, making owner compensation structure…
See the specialty and surgical clinics angleWe align every dollar your specialty or surgical clinic retains, distributes, or reinvests with your personal wealth…
See the specialty and surgical clinics angleWe design a capital allocation framework that ties each dollar to contribution margin per procedure, scheduling…
See the specialty and surgical clinics angleWe isolate contribution margin per procedure across your surgical schedule so you know which cases build value and…
See the specialty and surgical clinics angleSpecialty and surgical clinics command 5 to 17x EBITDA when buyers can verify contribution margin per procedure…
See the specialty and surgical clinics angleFractional CFO services for specialty and surgical clinics focus on contribution margin per procedure, scheduling…
See the specialty and surgical clinics angleProduction per provider, collection rate, and payer mix. Dental practice value lives in the hygiene schedule a
See advisory angleProfitability by provider, location, and payer. Multi-provider groups live and die by payer mix and provider p
See advisory angleRepeat revenue, provider productivity, and margin per service line. Med spas are valued on whether the model r
See advisory angleThe Keystone Value Creation Assessment™ audits your last 12 to 36 months and gives you a written summary whether you engage us or not. If there is not a clear opportunity to create value, we will tell you directly.